Salazopyrin-EN

Salazopyrin-EN may be available in the countries listed below.

Ingredient matches for Salazopyrin-EN

Sulfasalazine

Sulfasalazine is reported as an ingredient of Salazopyrin-EN in the following countries:

• Czech Republic


• Iceland


• Israel


• Norway


• Romania


• Singapore


• Sri Lanka


• Taiwan


• Thailand

International Drug Name Search

Oftaler

Oftaler may be available in the countries listed below.

Ingredient matches for Oftaler

Ketotifen

Ketotifen is reported as an ingredient of Oftaler in the following countries:

• Chile

International Drug Name Search

Saymotin S

Saymotin S may be available in the countries listed below.

Ingredient matches for Saymotin S

Kallidinogenase

Kallidinogenase is reported as an ingredient of Saymotin S in the following countries:

• Japan

International Drug Name Search

Omeprazolo Ranbaxy

Omeprazolo Ranbaxy may be available in the countries listed below.

Ingredient matches for Omeprazolo Ranbaxy

Omeprazole

Omeprazole is reported as an ingredient of Omeprazolo Ranbaxy in the following countries:

• Italy

International Drug Name Search

Dextromethorphan/Guaifenesin/Phenylephrine Liquid

Pronunciation: dex-troe-meth-OR-fan/gwye-FEN-eh-sin/fen-ill-EF-rin
Generic Name: Dextromethorphan/Guaifenesin/Phenylephrine
Brand Name: Examples include Tussidex and Zotex

Dextromethorphan/Guaifenesin/Phenylephrine Liquid is used for:

Relieving congestion, cough, and throat and airway irritation due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Dextromethorphan/Guaifenesin/Phenylephrine Liquid is a decongestant, cough suppressant, and expectorant combination. It works by constricting blood vessels and reducing swelling in the nasal passages, loosening mucus and lung secretions in the chest, and making coughs more productive. It also works in the brain to help decrease the cough reflex to reduce a dry cough.

Do NOT use Dextromethorphan/Guaifenesin/Phenylephrine Liquid if:

• you are allergic to any ingredient in Dextromethorphan/Guaifenesin/Phenylephrine Liquid


• you have severe high blood pressure, rapid heartbeat, or other severe heart problems (eg, heart blood vessel disease)


• you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Some medical conditions may interact with Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of glaucoma, an enlarged prostate gland or other prostate problems, heart problems, diabetes, high blood pressure, blood vessel problems, adrenal gland problems, an overactive thyroid, seizures, or stroke


• if you have a chronic cough, lung problems (eg, asthma, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

Some MEDICINES MAY INTERACT with Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), COMT inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline) because the risk of side effects from Dextromethorphan/Guaifenesin/Phenylephrine Liquid may be increased


• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Bromocriptine because the risk of side effects may be increased by Dextromethorphan/Guaifenesin/Phenylephrine Liquid


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dextromethorphan/Guaifenesin/Phenylephrine Liquid

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dextromethorphan/Guaifenesin/Phenylephrine Liquid may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Use Dextromethorphan/Guaifenesin/Phenylephrine Liquid as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may be taken with or without food.


• Drink plenty of water while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Dextromethorphan/Guaifenesin/Phenylephrine Liquid, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dextromethorphan/Guaifenesin/Phenylephrine Liquid.

Important safety information:

• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may cause dizziness or drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Using Dextromethorphan/Guaifenesin/Phenylephrine Liquid alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Do not take appetite suppressants while you are taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid without checking with your doctor.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid contains phenylephrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains phenylephrine. If it does or if you are uncertain, contact your doctor or pharmacist.


• Do NOT exceed the recommended dose or take Dextromethorphan/Guaifenesin/Phenylephrine Liquid for longer than prescribed without checking with your doctor.


• If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may interfere with certain lab test results. Make sure that all of your doctors and lab personnel know that you are taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Use Dextromethorphan/Guaifenesin/Phenylephrine Liquid with caution in the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Dextromethorphan/Guaifenesin/Phenylephrine Liquid in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid, discuss with your doctor the benefits and risks of using Dextromethorphan/Guaifenesin/Phenylephrine Liquid during pregnancy. It is unknown if Dextromethorphan/Guaifenesin/Phenylephrine Liquid is excreted in breast milk. Do not breast-feed while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.

Possible side effects of Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; excitability; headache; nausea; nervousness or anxiety; trouble sleeping; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dextromethorphan/Guaifenesin/Phenylephrine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Store Dextromethorphan/Guaifenesin/Phenylephrine Liquid at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dextromethorphan/Guaifenesin/Phenylephrine Liquid out of the reach of children and away from pets.

General information:

• If you have any questions about Dextromethorphan/Guaifenesin/Phenylephrine Liquid, please talk with your doctor, pharmacist, or other health care provider.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dextromethorphan/Guaifenesin/Phenylephrine Liquid. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dextromethorphan/Guaifenesin/Phenylephrine resources

• Dextromethorphan/Guaifenesin/Phenylephrine Side Effects (in more detail)
• Dextromethorphan/Guaifenesin/Phenylephrine Use in Pregnancy & Breastfeeding
• Dextromethorphan/Guaifenesin/Phenylephrine Drug Interactions
• Dextromethorphan/Guaifenesin/Phenylephrine Support Group
• 0 Reviews for Dextromethorphan/Guaifenesin/Phenylephrine - Add your own review/rating

Compare Dextromethorphan/Guaifenesin/Phenylephrine with other medications

• Cough and Nasal Congestion

Budesonide Sustained-Release Capsules

Pronunciation: byoo-DESS-oh-nide
Generic Name: Budesonide
Brand Name: Entocort EC

Budesonide Sustained-Release Capsules are used for:

Treating mild to moderate Crohn disease and maintaining remission for up to 3 months. It may also be used for other conditions as determined by your doctor.

Budesonide Sustained-Release Capsules are a corticosteroid. It works by decreasing inflammation.

Do NOT use Budesonide Sustained-Release Capsules if:

• you are allergic to any ingredient in Budesonide Sustained-Release Capsules


• you are taking mifepristone

Contact your doctor or health care provider right away if any of these apply to you.

Before using Budesonide Sustained-Release Capsules:

Some medical conditions may interact with Budesonide Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have heart problems; diabetes; esophagus inflammation; stomach problems; intestinal problems; heart attack; ulcer; kidney problems; liver disease; osteoporosis; high blood pressure; glaucoma; cataracts; a herpes eye infection; a bacterial, fungal, parasitic, or viral infection; diarrhea; measles; tuberculosis; chicken pox; or shingles


• if you have had a positive TB skin test or have recently been vaccinated

Some MEDICINES MAY INTERACT with Budesonide Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), or rifampin because they may decrease Budesonide Sustained-Release Capsules's effectiveness


• Clarithromycin, steroidal contraceptives (eg, birth control pills), or imidazole antifungals (eg, ketoconazole, itraconazole) because they may increase the risk of Budesonide Sustained-Release Capsules's side effects


• Ritodrine or live vaccines because the risk of their side effects may be increased by Budesonide Sustained-Release Capsules


• Hydantoins (eg, phenytoin) because their effectiveness may be decreased by Budesonide Sustained-Release Capsules


• Mifepristone because risk of side effects may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Budesonide Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Budesonide Sustained-Release Capsules:

Use Budesonide Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Budesonide Sustained-Release Capsules. Talk to your pharmacist if you have questions about this information.


• Take Budesonide Sustained-Release Capsules by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Budesonide Sustained-Release Capsules whole. Do not break, crush, or chew before swallowing.


• Use Budesonide Sustained-Release Capsules on a regular schedule to get the most benefit from it.


• Do not eat grapefruit or drink grapefruit juice while you use Budesonide Sustained-Release Capsules.


• If you miss a dose of Budesonide Sustained-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Budesonide Sustained-Release Capsules.

Important safety information:

• Budesonide Sustained-Release Capsules may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Take Budesonide Sustained-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Tell your doctor or dentist that you take Budesonide Sustained-Release Capsules before you receive any medical or dental care, emergency care, or surgery.


• Budesonide Sustained-Release Capsules may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.


• Do not receive a live vaccine (eg, measles, mumps) while you are taking Budesonide Sustained-Release Capsules. Talk with your doctor before you receive any vaccine.


• Diabetes patients - Budesonide Sustained-Release Capsules may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Lab tests, including adrenal function assessment, may be performed while you use Budesonide Sustained-Release Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Budesonide Sustained-Release Capsules should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Budesonide Sustained-Release Capsules while you are pregnant. Budesonide Sustained-Release Capsules are found in breast milk. Do not breast-feed while taking Budesonide Sustained-Release Capsules.

Possible side effects of Budesonide Sustained-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; changes in menstrual cycle; dizziness; gas; headache; indigestion; nausea; nervousness; pain; respiratory tract infection; stomach pain; tiredness; tremor; trouble sleeping; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); acne; change in mood or behavior; chest pain; confusion; severe headache; sudden increase in weight; swelling of the ankles; unusual bruising; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Budesonide Sustained-Release Capsules:

Store Budesonide Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Budesonide Sustained-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Budesonide Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Budesonide Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Budesonide Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Budesonide resources

• Budesonide Use in Pregnancy & Breastfeeding
• Budesonide Drug Interactions
• Budesonide Support Group
• 22 Reviews for Budesonide - Add your own review/rating

Compare Budesonide with other medications

• Asthma, Maintenance
• Autoimmune Hepatitis
• Crohn's Disease
• Crohn's Disease, Acute
• Crohn's Disease, Maintenance
• Eosinophilic Esophagitis
• Inflammatory Bowel Disease

Bronchospasmin

Bronchospasmin may be available in the countries listed below.

Ingredient matches for Bronchospasmin

Reproterol

Reproterol hydrochloride (a derivative of Reproterol) is reported as an ingredient of Bronchospasmin in the following countries:

• Germany

International Drug Name Search

Tylosin Animedica

Tylosin Animedica may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tylosin Animedica

Tylosin

Tylosin tartrate (a derivative of Tylosin) is reported as an ingredient of Tylosin Animedica in the following countries:

• Austria

International Drug Name Search

Secnidazole

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01AB07

CAS registry number (Chemical Abstracts Service)

0003366-95-8

Chemical Formula

C7-H11-N3-O3

Molecular Weight

185

Therapeutic Categories

Antiprotozoal agent, amebicide

Antiprotozoal agent: Trichomonacidal

Chemical Names

(RS)-1-(2-Methyl-5-nitro-1-imidazolyl)-2-propanol (IUPAC)

1-(2-Hydroxypropyl)-2-methyl-5-nitroimidazol

1H-Imidazole-1-ethanol, α,2-dimethyl-5-nitro-

α,2-Dimethyl-5-nitroimidazole-1-ethanol (WHO)

Foreign Names

• Secnidazolum (Latin)
• Secnidazol (German)
• Secnidazole (French)
• Secnidazol (Spanish)

Generic Names

• Secnidazole (OS: DCF, BAN)
• PM 185184 (IS)
• RP 14539 (IS: Specia)

Brand Names

• Ambese
  Biotech, Venezuela



• Amebin
  Solka, Costa Rica; Solka, Dominican Republic; Solka, Honduras; Solka, Nicaragua; Solka, El Salvador



• Amecdal
  Rodim, Belize; Rodim, Guatemala; Rodim, Honduras; Rodim, Nicaragua; Rodim, El Salvador



• Bianos
  Interpharm, Ecuador; Procaps, Colombia; Unimed, Peru



• Daksol
  Galeno, Colombia; La Santé, Venezuela



• Deprozol
  Aché, Brazil



• Ecuzol
  ECU, Ecuador



• Esnidazol
  H.G., Ecuador



• Fazol
  Dollder, Venezuela



• Flagentyl
  Aventis, Ghana; Aventis, Kenya; Aventis, Nigeria; Aventis, Zimbabwe; Eczacibasi, Turkey; Howse & McGeorge, Uganda; Sanofi-Aventis, Argentina; Sanofi-Aventis, Burkina Faso; Sanofi-Aventis, Benin; Sanofi-Aventis, Central African Republic; Sanofi-Aventis, Congo; Sanofi-Aventis, Cote D'ivoire; Sanofi-Aventis, Cameroon; Sanofi-Aventis, Gabon; Sanofi-Aventis, Guinea; Sanofi-Aventis, Madagascar; Sanofi-Aventis, Mali; Sanofi-Aventis, Mauritania; Sanofi-Aventis, Mauritius; Sanofi-Aventis, Niger; Sanofi-Aventis, Oman; Sanofi-Aventis, Senegal; Sanofi-Aventis, Chad; Sanofi-Aventis, Togo; Sanofi-Aventis, Vietnam; Sanofi-Aventis, Zaire; Vitoria, Portugal



• Gisistin
  Best, Mexico



• Gynerium
  Victory, Mexico



• Italnidazol
  Italpharma, Ecuador



• Maxidazol
  Ethical, Dominican Republic



• Minovag
  Novag, Mexico



• Noameba-DS
  Ipca, India



• Nor-Secnal
  Teramed, Dominican Republic; Teramed, Guatemala; Teramed, Honduras; Teramed, El Salvador



• Pazidol
  Life, Ecuador



• Pleyazen
  Weider, Colombia



• Raserdazol
  Raserpharm, Ecuador



• Sabima
  Atlantis, Mexico



• Secdazol
  Cheminter, Guatemala



• Secnezol
  Bosnalijek, Bosnia & Herzegowina



• Secnichem
  Biochem, Colombia



• Secnid
  Square, Bangladesh



• Secnidal
  Aventis, Brazil; Aventis, Peru; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Honduras; Sanofi-Aventis, Mexico; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Panama; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Venezuela



• Secnidazol Calox
  Calox, Venezuela



• Secnidazol Genfar
  Genfar, Colombia; Genfar, Ecuador; Genfar, Peru



• Secnidazol La Santé
  La Santé, Colombia



• Secnidazol MK
  McKesson, Ecuador; MK, Colombia



• Secnidazol
  AZ Pharma, Colombia; Calidad, Venezuela; Cofasa, Venezuela; Colmed, Peru; Genéricos Venezolanos, Venezuela; Grünenthal, Peru; Kimiceg, Venezuela; Medicalex, Colombia; Pentacoop, Colombia; Pentacoop, Peru; Genéricos RxI.M.G. Rx, Venezuela



• Secnihexal
  Hexal, Brazil



• Secnil
  Nicholas, India



• Secnimed
  Proanmed, Colombia



• Secni-Plus
  Farmoquimica, Brazil



• Secnivax
  Vivax, Venezuela



• Secnizol ratio
  Ratio, Dominican Republic



• Secnizol
  UCI, Brazil



• Secnol
  IPRAD, France; IPRAD, Luxembourg



• Secsilen
  Rocnarf, Ecuador



• Seczol
  Valmor, Venezuela



• Sezol
  ACI, Bangladesh



• Strebenzol
  Streger, Mexico



• Tagera Forte
  Unichem, Georgia; Unichem, Sri Lanka; Unichem, Vietnam



• Unidazol
  Zuoz, Venezuela



• Xamex
  Ariston, Ecuador



• Yardel
  Indunidas, Ecuador

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.